X
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/kazia-announces-the-release-of-pnoc022-clinical-study-abstract-highlighting-paxalisib-in-diffuse-midline-glioma-patients-ahead-of-the-society-of-neuro-oncology-2023-annual-meeting-301989147.html
https://www.prnewswire.com/news-releases/kazia-announces-publication-in-molecular-cancer-therapeutics-highlighting-paxalisib-preclinical-data-in-melanoma-301984365.html
https://www.prnewswire.com/news-releases/kazia-therapeutics-provides-preliminary-update-from-ongoing-phase-2-study-of-paxalisib-in-primary-cns-lymphoma-301973774.html
https://www.benzinga.com/news/22/10/29166532/pnoc-clinical-study-of-kazias-paxalisib-in-childhood-brain-cancer-expands-internationally
https://www.prnewswire.com/news-releases/kazia-therapeutics-reports-promising-interim-data-from-combination-study-of-paxalisib-with-radiotherapy-in-treatment-of-brain-metastases-301600774.html
https://www.fiercebiotech.com/clinical-data/kazia-dropped-global-clinical-relay-race-treat-aggressive-form-brain-cancer
https://www.prnewswire.com/news-releases/us-fda-awards-rare-pediatric-disease-designation-rpdd-to-paxalisib-for-atrt-a-rare-form-of-childhood-brain-cancer-301581006.html
https://www.prnewswire.com/news-releases/us-fda-awards-orphan-drug-designation-odd-to-paxalisib-for-atrt-a-rare-form-of-childhood-brain-cancer-301570078.html
https://www.clinicaltrialsarena.com/news/kazia-glioblastoma-therapy-trial/
https://www.prnewswire.com/news-releases/kazia-announces-positive-final-data-from-phase-ii-clinical-study-of-paxalisib-in-newly-diagnosed-glioblastoma-301437472.html
https://www.prnewswire.com/news-releases/kazia-provides-progress-update-on-paxalisib-and-evt801-clinical-programs-301322699.html
https://www.prnewswire.com/news-releases/us-fda-awards-orphan-drug-designation-odd-to-paxalisib-for-malignant-glioma-including-dipg-301116764.html
https://www.prnewswire.com/news-releases/us-fda-awards-orphan-drug-designation-odd-to-paxalisib-for-malignant-glioma-including-dipg-301116764.html
https://www.targetedonc.com/view/fda-grants-fast-track-designation-to-paxalisib-in-glioblastoma
https://www.prnewswire.com/news-releases/kazia-presents-further-paxalisib-and-cantrixil-data-at-aacr-reinforcing-positive-efficacy-signals-for-both-drugs-301080823.html
https://www.prnewswire.com/news-releases/kazia-presents-interim-paxalisib-phase-ii-data-at-asco-showing-positive-overall-survival-signal-301068275.html
Market Place
Share 
